Tony Koutsoukos

599 total citations
16 papers, 396 citations indexed

About

Tony Koutsoukos is a scholar working on Epidemiology, Pathology and Forensic Medicine and Dermatology. According to data from OpenAlex, Tony Koutsoukos has authored 16 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Pathology and Forensic Medicine and 5 papers in Dermatology. Recurrent topics in Tony Koutsoukos's work include Lymphoma Diagnosis and Treatment (6 papers), Inflammatory Myopathies and Dermatomyositis (5 papers) and Cutaneous lymphoproliferative disorders research (5 papers). Tony Koutsoukos is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Inflammatory Myopathies and Dermatomyositis (5 papers) and Cutaneous lymphoproliferative disorders research (5 papers). Tony Koutsoukos collaborates with scholars based in United States, France and United Kingdom. Tony Koutsoukos's co-authors include Qi Jiang, Steven Snapinn, Sarah McCue Horwitz, Owen A. O’Connor, Andrei R. Shustov, Nancy L. Bartlett, Jasmine Zain, Patricia L. Myskowski, Madeleine Duvic and Mary Jo Lechowicz and has published in prestigious journals such as Blood, Neurology and Epilepsia.

In The Last Decade

Tony Koutsoukos

16 papers receiving 393 citations

Peers

Countries citing papers authored by Tony Koutsoukos

Since Specialization

Citations

This map shows the geographic impact of Tony Koutsoukos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tony Koutsoukos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tony Koutsoukos more than expected).

Fields of papers citing papers by Tony Koutsoukos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tony Koutsoukos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tony Koutsoukos. The network helps show where Tony Koutsoukos may publish in the future.

Co-authorship network of co-authors of Tony Koutsoukos

This figure shows the co-authorship network connecting the top 25 collaborators of Tony Koutsoukos. A scholar is included among the top collaborators of Tony Koutsoukos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tony Koutsoukos. Tony Koutsoukos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Triheptanoin Did Not Show Benefit versus Placebo for the Treatment of Paroxysmal Movement Disorders in Glut1 Deficiency Syndrome: Results of a Randomized Phase 3 Study 2024 ·Movement Disorders ·Valentina De Giorgis, Kailash P. Bhatia, Odile Boespflug‐Tanguy, Domitille Gras, Adela Della Marina, Archana Desurkar, Manuel Toledo, Ian Miller, Michael Rotstein, Susanne A. Schneider, Daniel Tarquinio, Yvonne Weber, Melanie Brandabur, J. Mayhew, Tony Koutsoukos, Darryl C. De Vivo	4
2	A randomized, double‐blind trial of triheptanoin for drug‐resistant epilepsy in glucose transporter 1 deficiency syndrome 2022 ·Epilepsia ·Pasquale Striano, Stéphane Auvin, Abigail Collins, Rita Horváth, Ingrid E. Scheffer, Michal Tzadok, Ian Miller, Mary Kay Koenig, (unknown), Ronald W. Davis, (unknown), Russell P. Saneto, Melanie Brandabur, Susan Blair, Tony Koutsoukos, Darryl C. De Vivo	21
3	Results from a 3-year Non-interventional, Observational Disease Monitoring Program in Adults with GNE Myopathy 2021 ·Journal of Neuromuscular Diseases ·Hanns Lochmüller, Anthony Béhin, Ivailo Tournev, Mark A. Tarnopolsky, Rita Horváth, Oksana Pogoryelova, (unknown), Tony Koutsoukos, Alison Skrinar, Emil Kakkis, Camille L. Bedrosian, Tahseen Mozaffar	10
4	Retrospective chart review of urinary glycosaminoglycan excretion and long-term clinical outcomes of enzyme replacement therapy in patients with mucopolysaccharidoses 2020 ·Molecular Genetics and Metabolism ·Simon Jones, Deborah Marsden, Tony Koutsoukos, (unknown), Karen Tylee, (unknown), Emil Kakkis	4
5	A phase 3 randomized study evaluating sialic acid extended-release for GNE myopathy 2019 ·Neurology ·Hanns Lochmüller, Anthony Béhin, Yoseph Caraco, Heather Lau, Massimiliano Mirabella, Ivailo Tournev, Mark A. Tarnopolsky, Oksana Pogoryelova, C. G. Woods, (unknown), (unknown), Tony Koutsoukos, Alison Skrinar, Hank Mansbach, Emil Kakkis, Tahseen Mozaffar	49
6	GNE-myopathy (HIBM): Upper and lower extremity muscle strength declines over time in a prospective study 2017 ·Neuromuscular Disorders ·Anthony Béhin, Tahseen Mozaffar, Mark A. Tarnopolsky, Teresa Gidaro, Oksana Pogoryelova, Jay Shah, (unknown), Tony Koutsoukos, Ivailo Tournev, Hanns Lochmüller	1
7	Aceneuramic Acid Extended Release Administration Maintains Upper Limb Muscle Strength in a 48-week Study of Subjects with GNE Myopathy: Results from a Phase 2, Randomized, Controlled Study 2016 ·Journal of Neuromuscular Diseases ·Zohar Argov, Yoseph Caraco, Heather Lau, Alan Pestronk, Perry B. Shieh, Alison Skrinar, Tony Koutsoukos, (unknown), (unknown), Emil Kakkis	32
8	Upper and lower extremity muscle strength decline over 1 year in a prospective, observational GNE-myopathy natural history study 2016 ·Neuromuscular Disorders ·Mark A. Tarnopolsky, Tahseen Mozaffar, Anthony Béhin, Teresa Gidaro, Oksana Pogoryelova, (unknown), Tony Koutsoukos, (unknown), Hanns Lochmüller	1
9	Pralatrexate Is an Effective Treatment for Relapsed or Refractory Transformed Mycosis Fungoides: A Subgroup Efficacy Analysis From the PROPEL Study 2012 ·Clinical Lymphoma Myeloma & Leukemia ·Francine M. Foss, Sarah McCue Horwitz, Bertrand Coiffier, Nancy L. Bartlett, Leslie Popplewell, Barbara Pro, Lauren Pinter‐Brown, Andrei R. Shustov, Richard R. Furman, Corinne Haïoun, Tony Koutsoukos, Owen A. O’Connor	45
10	Randomized Phase 2b Study of Pralatrexate Versus Erlotinib in Patients With Stage IIIB/IV Non–Small-Cell Lung Cancer (NSCLC) After Failure of Prior Platinum-Based Therapy 2012 ·Journal of Thoracic Oncology ·Karen Kelly, Christopher G. Azzoli, Petr Zatloukal, István Albert, Peter Jiang, David Bodkin, José Rodrigues Pereira, Erzsébet Juhász, Nicholas Iannotti, (unknown), Tony Koutsoukos, Jyoti D. Patel	26
11	Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma 2012 ·Blood ·Sarah McCue Horwitz, Youn H. Kim, Francine Foss, Jasmine Zain, Patricia L. Myskowski, Mary Jo Lechowicz, David C. Fisher, Andrei R. Shustov, Nancy L. Bartlett, Maria Delioukina, Tony Koutsoukos, M. Saunders, Owen A. O’Connor, Madeleine Duvic	101
12	Pralatrexate Reverses the Trend to Progressive Resistance to Successive Systemic Treatment Regimens In Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) 2010 ·Blood ·Owen A. O’Connor, (unknown), Pier Luigi Zinzani, Christian Gisselbrecht, Francine M. Foss, (unknown), Barbara Pro, Lauren Pinter‐Brown, Nancy L. Bartlett, Sarah McCue Horwitz, Eric D. Jacobsen, Tony Koutsoukos, Steven Fruchtman, Bertrand Coiffier	1
13	Pralatrexate Is An Effective Treatment for Heavily Pretreated Patients with Relapsed/Refractory Transformed Mycosis Fungoides (tMF) 2010 ·Blood ·Francine M. Foss, Sarah McCue Horwitz, Lauren Pinter‐Brown, André Goy, Barbara Pro, Bertrand Coiffier, Leslie Popplewell, (unknown), Andrei R. Shustov, Jasmine Zain, Tony Koutsoukos, Steven Fruchtman, Owen A. O’Connor	14
14	Identification of An Active, Well-Tolerated Dose of Pralatrexate In Patients with Relapsed or Refractory Cutaneous T-Cell Lymphoma (CTCL): Final Results of a Multicenter Dose-Finding Study. 2010 ·Blood ·Sarah McCue Horwitz, Youn H. Kim, Francine M. Foss, Jasmine Zain, Patricia L. Myskowski, Mary Jo Lechowicz, David C. Fisher, Andrei R. Shustov, Nancy L. Bartlett, Maria Delioukina, Tony Koutsoukos, Steven Fruchtman, Owen A. O’Connor, Madeleine Duvic	13
15	Pralatrexate (PDX) IS Active in Cutaneous T-Cell Lymphoma: Preliminary Results of a Multi-Center Dose-Finding Trial. 2008 ·Blood ·Sarah McCue Horwitz, Madeleine Duvic, Hyun Soo Kim, Jasmine Zain, Mary Jo Lechowicz, Patricia L. Myskowski, Hanna Weissbrot, (unknown), (unknown), Tony Koutsoukos, Pablo J. Cagnoni, Michael Saunders, Owen A. O’Connor	9
16	Assessment of futility in clinical trials 2006 ·Pharmaceutical Statistics ·Steven Snapinn, (unknown), Qi Jiang, Tony Koutsoukos	65

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact